0.321
0.32 (-0.65%)
As of Feb 12, 2024
Invivo Therapeutics Holdings Corp. [NVIV]
Source:
Company Overview
Invivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries, or SCIs. Our mission is to redefine the life of the SCI patient.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | 617-863-5524 |
Industry | manufacturing |
CEO | Richard Toselli |
Website | www.invivotherapeutics.com |